Therapeutic Asset Ratings
13,155 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Trifluridine
Rectal Carcinoma
Sun Yat-sen University
P2
B
(60)
Trilaciclib
Myelosuppression, Non-Human Animal
The First Affiliated Hospital of Xiamen University
P2
B
(60)
Tucatinib
Estrogen-Receptor Positive Breast Cancer
Dana-Farber Cancer Institute
P2
B
(60)
Tucatinib
Gastric Cancer
Seagen, a wholly owned subsidiary of Pfizer
P2
B
(60)
Tucidinostat
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Peking Union Medical College Hospital
P2
B
(60)
Tucidinostat
Hormone Receptor-Positive Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
P2
B
(60)
Tucidinostat
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Sun Yat-sen University
P2
B
(60)
Vancomycin
Inflammatory Bowel Disease
Tampere University Hospital
P2
B
(60)
Veliparib
Essential Thrombocythemia
National Cancer Institute (NCI)
P2
B
(60)
Veliparib
Acquired Polycythemia Vera
National Cancer Institute (NCI)
P2
B
(60)
Vemurafenib
Breast Cancer
OHSU Knight Cancer Institute
P2
B
(60)
Vemurafenib
Malignant Pancreatic Neoplasm
OHSU Knight Cancer Institute
P2
B
(60)
Venetoclax
Acute Monocytic Leukemia
OHSU Knight Cancer Institute
P2
B
(60)
Venetoclax
Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication
First Affiliated Hospital of Zhejiang University
P2
B
(60)
Venetoclax
CD4+/CD56+ Hematodermic Neoplasm
French Innovative Leukemia Organisation
P2
B
(60)
Venetoclax
Myelodysplastic Syndrome With Excess Blasts-2
Aptose Biosciences Inc.
P2
B
(60)
Venetoclax
Mixed Phenotype Acute Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P2
B
(60)
Venetoclax
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
P2
B
(60)
(+)-Vincristine
Acute Myeloid Leukemia With BCR-ABL1
M.D. Anderson Cancer Center
P2
B
(60)
(+)-Vincristine
CD4+/CD56+ Hematodermic Neoplasm
Therapeutic Advances in Childhood Leukemia Consortium
P2
B
(60)
(+)-Vincristine
Cognitive Impairment - Coarse Facies - Heart Defects - Obesity - Pulmonary Involvement - Short Stature - Skeletal Dysplasia Syndrome
Fudan University
P2
B
(60)
(+)-Vincristine
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
Li Zhiming
P2
B
(60)
(+)-Vincristine
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
Patrick C. Johnson, MD
P2
B
(60)
(+)-Vincristine
T-Lymphoblastic Lymphoma
National Cancer Institute (NCI)
P2
B
(60)
(+)-Vincristine
Rhabdomyosarcoma
Theodore Laetsch
P2
B
(60)
Showing 2226 to 2250 of 13,155 assets
Previous
Page 90 of 527
Next